Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.

Li H, Estabrook M, Jacoby GA, Nichols WW, Testa RT, Bush K.

Antimicrob Agents Chemother. 2015 Mar;59(3):1789-93. doi: 10.1128/AAC.04191-14. Epub 2014 Dec 22.

2.

Synthesis and antibacterial activity of 9-substituted minocycline derivatives.

Sum PE, Ross AT, Petersen PJ, Testa RT.

Bioorg Med Chem Lett. 2006 Jan 15;16(2):400-3. Epub 2005 Oct 21.

PMID:
16246559
3.

Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activities.

Singh MP, Petersen PJ, Weiss WJ, Janso JE, Luckman SW, Lenoy EB, Bradford PA, Testa RT, Greenstein M.

Antimicrob Agents Chemother. 2003 Jan;47(1):62-9.

4.

Comparative efficacy of new investigational agents against Helicobacter pylori.

Osato MS, Reddy SG, Piergies AA, Bochenek WJ, Testa RT, Graham DY.

Aliment Pharmacol Ther. 2001 Apr;15(4):487-92.

6.

In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT.

Antimicrob Agents Chemother. 1999 Apr;43(4):738-44.

7.

In vivo activities of peptidic prodrugs of novel aminomethyl tetrahydrofuranyl-1 beta-methylcarbapenems.

Weiss WJ, Mikels SM, Petersen PJ, Jacobus NV, Bitha P, Lin YI, Testa RT.

Antimicrob Agents Chemother. 1999 Mar;43(3):460-4.

8.

In vitro activities of aminomethyl-substituted analogs of novel tetrahydrofuranyl carbapenems.

Weiss WJ, Petersen PJ, Jacobus NV, Lin YI, Bitha P, Testa RT.

Antimicrob Agents Chemother. 1999 Mar;43(3):454-9.

9.

Streptomyces stramineus sp. nov., a new species of the verticillate streptomycetes.

Labeda DP, Lechevalier MP, Testa RT.

Int J Syst Bacteriol. 1997 Jul;47(3):747-53.

PMID:
9226907
10.

In vitro activity of piperacillin/tazobactam against isolates from patients enrolled in clinical trials.

Kuck NA, Jacobus NV, Spengler MD, Testa RT.

Int J Antimicrob Agents. 1996 May;7(1):15-21.

PMID:
18611730
11.

Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines.

Weiss WJ, Jacobus NV, Petersen PJ, Testa RT.

J Antimicrob Chemother. 1995 Jul;36(1):225-30.

PMID:
8537270
12.

Glycylcyclines: a new generation of tetracyclines.

Tally FT, Ellestad GA, Testa RT.

J Antimicrob Chemother. 1995 Apr;35(4):449-52. Review. No abstract available.

PMID:
7628979
13.

Sulfinemycin, a new anthelmintic antibiotic: fermentation, isolation and structure determination.

Lee TM, Siegel MM, Morton GO, Goodman JJ, Testa RT, Borders DB.

J Antibiot (Tokyo). 1995 Mar;48(3):282-5. No abstract available.

14.

"Glycylcyclines". 3. 9-Aminodoxycyclinecarboxamides.

Barden TC, Buckwalter BL, Testa RT, Petersen PJ, Lee VJ.

J Med Chem. 1994 Sep 30;37(20):3205-11.

PMID:
7932547
15.

Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.

Sum PE, Lee VJ, Testa RT, Hlavka JJ, Ellestad GA, Bloom JD, Gluzman Y, Tally FP.

J Med Chem. 1994 Jan 7;37(1):184-8.

PMID:
8289194
16.

In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.

Testa RT, Petersen PJ, Jacobus NV, Sum PE, Lee VJ, Tally FP.

Antimicrob Agents Chemother. 1993 Nov;37(11):2270-7.

17.

Synthesis and biological activity of derivatives of glycopeptide antibiotics eremomycin and vancomycin nitrosated, acylated or carbamoylated at the N-terminal.

Pavlov AY, Berdnikova TF, Olsufyeva EN, Lazhko EI, Malkova IV, Preobrazhenskaya MN, Testa RT, Petersen PJ.

J Antibiot (Tokyo). 1993 Nov;46(11):1731-9.

18.

Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactam.

Jacobus NV, Immermann FW, Gupte JM, Testa RT.

Clin Infect Dis. 1993 Jun;16 Suppl 4:S344-8. No abstract available.

PMID:
8391862
19.

LL-AF283 antibiotics, cyclic biphenyl peptides.

Chang CC, Morton GO, James JC, Siegel MM, Kuck NA, Testa RT, Borders DB.

J Antibiot (Tokyo). 1991 Jun;44(6):674-7. No abstract available.

20.

In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.

Petersen PJ, Jacobus NV, Weiss WJ, Testa RT.

Antimicrob Agents Chemother. 1991 Jan;35(1):203-7.

21.

Pyrido[3,4-e]-1,2,4-triazines and related heterocycles as potential antifungal agents.

Reich MF, Fabio PF, Lee VJ, Kuck NA, Testa RT.

J Med Chem. 1989 Nov;32(11):2474-85.

PMID:
2810336
22.

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.

Kuck NA, Jacobus NV, Petersen PJ, Weiss WJ, Testa RT.

Antimicrob Agents Chemother. 1989 Nov;33(11):1964-9.

23.

Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.

Kuck NA, Petersen PJ, Weiss WJ, Jacobus NV, Testa RT, Tally FP.

J Chemother. 1989 Jul;1(4 Suppl):105-6. No abstract available.

PMID:
16312325
25.

In vitro and in vivo efficacy of YTR-830H and piperacillin combinations versus beta-lactamase-producing bacteria.

Kuck NA, Petersen PJ, Weiss WJ, Testa RT.

J Chemother. 1989 Jun;1(3):155-61.

PMID:
2552030
26.

Pyrido [3,4-e]-1,2,4-triazines and related heterocycles as potential antifungal agents.

Reich MF, Fabio PF, Lee VJ, Kuck NA, Testa RT.

Ann N Y Acad Sci. 1988;544:101-4. No abstract available.

PMID:
3214060
27.

New antitumor antibiotic, LL-D05139 beta. Fermentation, isolation, structure determination and biological activities.

Lee MD, Fantini AA, Kuck NA, Greenstein M, Testa RT, Borders DB.

J Antibiot (Tokyo). 1987 Dec;40(12):1657-63.

28.

LL-F42248 alpha, a novel chlorinated pyrrole antibiotic.

Carter GT, Nietsche JA, Goodman JJ, Torrey MJ, Dunne TS, Borders DB, Testa RT.

J Antibiot (Tokyo). 1987 Feb;40(2):233-6. No abstract available.

29.

New antitumor antibiotic, LL-C10037 alpha. Fermentation, isolation and structure determination.

Lee MD, Fantini AA, Morton GO, James JC, Borders DB, Testa RT.

J Antibiot (Tokyo). 1984 Oct;37(10):1149-52.

30.

In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics.

Kuck NA, Testa RT, Forbes M.

Antimicrob Agents Chemother. 1981 Apr;19(4):634-8.

31.

Biosynthesis of sisomicin and gentamicin.

Testa RT, Tilley BC.

Jpn J Antibiot. 1979 Dec;32 Suppl:S47-59. Review. No abstract available.

PMID:
398907
32.

A new broad spectrum aminoglycoside antibiotic, G-52, produced by Micromonospora zionensis.

Marquez JA, Wagman GH, Testa RT, Waitz JA, Weinstein MJ.

J Antibiot (Tokyo). 1976 May;29(5):483-7.

33.

Biotransformation, a new approach to aminoglycoside biosynthesis: II. Gentamicin.

Testa RT, Tilley BC.

J Antibiot (Tokyo). 1976 Feb;29(2):140-6.

34.

Biotransformation, a new approach to aminoglycoside biosynthesis. I. Sisomicin.

Testa RT, Tilley BC.

J Antibiot (Tokyo). 1975 Aug;28(8):573-9.

35.

New polyene antifungal antibiotic produced by a species of Actinoplanes.

Wagman GH, Testa RT, Patel M, Marquez JA, Oden EM, Waitz JA, Weinstein MJ.

Antimicrob Agents Chemother. 1975 Apr;7(4):457-61.

36.

Verdamicin, a new broad spectrum aminoglycoside antibiotic.

Weinstein MJ, Wagman GH, Marquez JA, Testa RT, Waitz JA.

Antimicrob Agents Chemother. 1975 Mar;7(3):246-9.

37.

Mutamicins; biosynthetically created new sisomicin analogues.

Testa RT, Wagman GH, Daniels PJ, Weinstein MJ.

J Antibiot (Tokyo). 1974 Dec;27(12):917-21. No abstract available.

38.
39.

Incorporation of L-methionine-methyl-14C into gentamicins.

Lee BK, Testa RT, Wagman GH, Liu CM, McDaniel L, Schaffner C.

J Antibiot (Tokyo). 1973 Dec;26(12):728-31. No abstract available.

40.

A new Micromonospora-produced macrolide antibiotic, rosamicin.

Wagman GH, Waitz JA, Marquez J, Murawaski A, Oden EM, Testa RT, Weinstein MJ.

J Antibiot (Tokyo). 1972 Nov;25(11):641-6. No abstract available.

41.

Antibiotic 6640. II. Fermentation, isolation, and properties.

Wagman GH, Testa RT, Marquez JA.

J Antibiot (Tokyo). 1970 Nov;23(11):555-8. No abstract available.

42.

Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic.

Weinstein MJ, Marquez JA, Testa RT, Wagman GH, Oden EM, Waitz JA.

J Antibiot (Tokyo). 1970 Nov;23(11):551-4. No abstract available.

43.

Megalomicin, a new macrolide antibiotic complex produced by Micromonospora.

Weinstein MJ, Wagman GH, Marquez JA, Testa RT, Oden E, Waitz JA.

J Antibiot (Tokyo). 1969 Jun;22(6):253-8. No abstract available.

44.

Preliminary studies on megalomicin, a new Micromonospora-produced macrolide antibiotic complex.

Weinstein MJ, Wagman GH, Marquez J, Oden E, Testa RT, Waitz JA.

Antimicrob Agents Chemother (Bethesda). 1968;8:260-1. No abstract available.

PMID:
5735370

Supplemental Content

Loading ...
Support Center